XTRA:AFXMedical Equipment
Is Carl Zeiss Meditec’s (XTRA:AFX) Oncology Imaging Push Quietly Redefining Its Long‑Term Growth Story?
In November 2025, FluoGuide A/S announced a non-exclusive collaboration agreement with ZEISS Medical Technologies to advance FG001 for tumor imaging and surgical margin assessment in head and neck cancer, focused on supporting the clinical phase and with no initial payment or expected financial impact in 2025.
This partnership underlines Carl Zeiss Meditec’s continued push into precision oncology imaging, where integrating advanced optics with novel tracers could broaden its long-term...